New Report Outlines How to Improve Quality, Regulatory, and Global-Trade Compliance Effectiveness
CHAPEL HILL, N.C., May. 29, 2020/PRNewswire/ -- Regulatory Affairs, Quality, and Global Trade Compliance leadership face the daunting task of ensuring compliance with the stringent regulations that surround the development and commercialization of drugs and medical devices.
These groups face a balancing act between managing resources, ensuring product quality and compliance, and adding value for patients and healthcare providers.
Best Practices, LLC conducted this benchmarking research to identify how leading pharmaceutical and medical device companies are improving the effectiveness of their Quality, Regulatory, and Global-Trade Compliance functions to support their service and product portfolio. This report also identifies effective structures, staffing levels, budget levels, processes, development and designs, and service levels.
"Developing Superior Global Quality, Regulatory, and Global-Trade Compliance Operations" aims to provide best practices on how to modify the RA/QA organization to support to companies’ service and product portfolio within the more heavily regulated Clinical & Diagnostic and Pharma & Biotech global markets.
Some of the areas examined in this report include:
- Quality Assurance
- Quality Assurance Staffing & Investment
- Quality Control
- Quality Control Staffing & Investment
- Structure
- Process
- Development & Design
- Service Levels
- Regulatory Affairs
- Regulatory Affairs Staffing & Investment
- Structure
- Process
- Service Levels
- Regulatory Compliance
- Regulatory Compliance Staffing & Investment
- Structure
- Process
- Service Levels
- Global Trade Compliance
- Global Trade Compliance Staffing & Investment
- Process & Service Levels
The full 137-page report contains more than 1,500 metrics, providing quality leaders with critical benchmarks that will allow them to compare their operations with those of leading organizations.
Review a complimentary summary of the study at https://www.best-in-class.com/rw107.htm.
Best Practices, LLC engaged 24 leaders from 22 life sciences and medical device companies in this research through a benchmarking survey. More than 80% of the benchmark class serves at the director level and above.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.